MedTrace Logo

Granisetron in Diabetic Parturients Decrease Spinal Induced Hypotension

NCT03091881 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2022-06-09

No results posted yet for this study

Summary

Diabetic Parturients are exposed to intraoperative hypotension after spinal anesthesia and we proposed that intravenous Granisterone 1 mg will attenuate the hypotension occurred with spinal block during Cesarean sections.

Conditions

  • Spinal-induced Hypotension

Interventions

DRUG

Granisetron 0.1 MG/ML

Granisetron 0.1 MG/ML Will be given 10 min before spinal block

DRUG

Placebos

Placebos will be given 10 min before spinal block

Sponsors & Collaborators

  • Suez Canal University

    lead OTHER

Principal Investigators

  • Mohamed A Elsadany, M.D · Suez Canal University, Faculty of Medicine, Anesthesia and Intensive Care Department

  • Amr M Helmy, M.D · Suez Canal University, Faculty of Medicine, Anesthesia and Intensive Care Department

  • Emad E Ahmed, M.D · Suez Canal University, Faculty of Medicine, Anesthesia and Intensive Care Department

  • Abdelrhman Alshawadfy, M.D · Suez Canal University, Faculty of Medicine, Anesthesia and Intensive Care Department

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2018-09-01
Completion
2018-11-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03091881 on ClinicalTrials.gov